google-site-verification: googlec7193c3de77668c9.html
Saturday , September 5 2026

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease, beta thalassemia

[
A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical centers prepare to meet growing demand for gene therapies in the coming years. The study was presented at the 67th ASH Annual Meeting and Exposition held 6–9 December, in Orlando, Florida.


Source link

Advertisements

See also  Team reports on prevalence in Middle East of cancers associated with human papillomavirus

Check Also

People affected by cancer need a stronger voice in shaping generative AI for oncology, review finds

[ Credit: Unsplash/CC0 Public Domain Flinders University researchers were part of an international team that …

Children’s suicide-related emergency visits spiked by 74% in the US between 2016–2022

[ Credit: Unsplash/CC0 Public Domain Emergency visits by children with suicide-related crises increased by 74% …

National call to action needed to strengthen primary care pipeline in medical education, argue experts

[ A new paper led by a faculty member at the Hackensack Meridian School of …

Leave a Reply

Available for Amazon Prime